FDA inspection
Granules India Limited: FDA inspection ending Mar 23, 2018
FDA inspection 1050607 · No Action Indicated (NAI) · Medchal-Malkhajgiri District
Key facts
| Inspection ID | 1050607 |
|---|---|
| Firm | Granules India Limited |
| FEI number | 3004097901 |
| Address | Survey No 160/A, 161/E, 162 And 174/A, Gagillapur Village, Dundigal-Gandimaisamma Mandal |
| City | Medchal-Malkhajgiri District |
| Country | India |
| Fiscal year | 2018 |
| Inspection end date | Mar 23, 2018 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data